T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
The Bancorp
TBBK
$2.83B
| $498K | ﹤0.01% |
19,682
-852
| -4% | -$24.6K |
|
|
AGTC
2377
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $498K | ﹤0.01% |
262,055
-10,100
| -4% | -$24.2K |
|
|
DMC
2378
Del Monte Corp
DMC
$1.42B
| $497K | ﹤0.01% |
18,024
-600
| -3% | -$17.7K |
|
2379
iShares National Muni Bond ETF
MUB
$45.9B
| $497K | ﹤0.01% |
4,275
-1,245
| -23% | -$145K |
|
|
FSR
2380
DELISTED
Fisker Inc.
FSR
| $493K | ﹤0.01% |
31,334
-28,306
| -47% | -$490K |
|
|
ECHO
2381
EchoStar
ECHO
$26.6B
| $491K | ﹤0.01% |
18,643
-1,912
| -9% | -$50.5K |
|
|
RTL
2382
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $490K | ﹤0.01% |
53,657
-1,650
| -3% | -$14K |
|
|
BRSP
2383
BrightSpire Capital
BRSP
$628M
| $489K | ﹤0.01% |
47,632
-1,552
| -3% | -$15K |
|
2384
Central Pacific Financial
CPF
$1B
| $487K | ﹤0.01% |
17,296
-548
| -3% | -$15K |
|
|
VBTX
2385
DELISTED
Veritex Holdings
VBTX
| $487K | ﹤0.01% |
12,244
-822
| -6% | -$33.3K |
|
2386
Corcept Therapeutics
CORT
$12.1B
| $486K | ﹤0.01% |
24,537
-18,226
| -43% | -$370K |
|
2387
iHeartMedia
IHRT
$450M
| $485K | ﹤0.01% |
23,036
-12,251
| -35% | -$259K |
|
2388
Conduent
CNDT
$241M
| $480K | ﹤0.01% |
89,927
-2,948
| -3% | -$17.6K |
|
|
CDMO
2389
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $480K | ﹤0.01% |
+16,447
| New | +$471K |
|
|
VLDR
2390
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $480K | ﹤0.01% |
+103,394
| New | +$604K |
|
2391
Laureate Education
LAUR
$5.1B
| $479K | ﹤0.01% |
39,097
-1,598
| -4% | -$20.9K |
|
|
AAN
2392
DELISTED
The Aaron's Company Inc
AAN
| $479K | ﹤0.01% |
19,429
-25,718
| -57% | -$657K |
|
|
SCS
2393
DELISTED
Steelcase
SCS
| $478K | ﹤0.01% |
40,751
-1,557
| -4% | -$18.8K |
|
2394
Groupon
GRPN
$901M
| $476K | ﹤0.01% |
20,567
+4,700
| +30% | +$110K |
|
2395
PJT Partners
PJT
$4.36B
| $476K | ﹤0.01% |
6,420
-408
| -6% | -$32.5K |
|
|
FBC
2396
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $476K | ﹤0.01% |
9,928
-860
| -8% | -$42.7K |
|
2397
Microvision
MVIS
$89.7M
| $474K | ﹤0.01% |
6,303
+974
| +18% | +$116K |
|
2398
NETGEAR
NTGR
$658M
| $474K | ﹤0.01% |
16,223
-568
| -3% | -$16.9K |
|
|
BASE
2399
DELISTED
Couchbase
BASE
| $473K | ﹤0.01% |
+18,965
| New | +$626K |
|
|
OLP
2400
One Liberty Properties
OLP
$523M
| $472K | ﹤0.01% |
13,392
+2,129
| +19% | +$70.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.